Cancer Epidemiology
Volume 34, Issue 2 , Pages 150-156 , April 2010

Genetic polymorphism of epidermal growth factor 61A>G and cancer risk: A meta-analysis

  • Yan-Mei Zhang

      Affiliations

    • Department of Internal Medicine, the Second Hospital of Anhui Medical University, 678 Furong Road, Hefei 230601, China
    • These authors have contributed equally to this work.
    • Corresponding Author InformationCorresponding author. Tel.: +86 15156086973; fax: +86 05513869627.
    • ,
  • Chao Cao

      Affiliations

    • Department of Respiratory Medicine, the Affiliated Hospital of School of Medicine, Ningbo University, Ningbo 315020, China
    • These authors have contributed equally to this work.
    • ,
  • Kun Liang

      Affiliations

    • Department of Basic Medicine, College of Basic Medicine, Anhui Medical University, Hefei 230601, China

,Accepted 9 February 2010.

References 

  1. Gleave ME, Hsieh JT, Wu HC, Hong SJ, Zhau HE, Guthrie PD, et al. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma. Cancer Res. 1993;53:5300–5307
  2. Normanno N, Bianco C, De Luca A, Salomon DS. The role of EGF-related peptides in tumor growth. Front Biosci. 2001;6:685–707
  3. Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol. 1995;19:183–232
  4. Fisher DA, Lakshmanan J. Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev. 1990;11:418–442
  5. Groenen LC, Nice EC, Burgess AW. Structure–function relationships for the EGF/TGF-alpha family of mitogens. Growth Factors. 1994;11:235–257
  6. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW, et al. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res. 2003;284:31–53
  7. Stoscheck CM, King LE. Role of epidermal growth factor in carcinogenesis. Cancer Res. 1986;46:1030–1037
  8. Singletary SE, Baker FL, Spitzer G, Tucker SL, Tomasovic B, Brock WA, et al. Biological effect of epidermal growth factor on the in vitro growth of human tumors. Cancer Res. 1987;47:403–406
  9. Jacobs EJ, Hsing AW, Bain EB, Stevens VL, Wang Y, Chen J, et al. Polymorphisms in angiogenesis-related genes and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:972–977
  10. Araújo A, Ribeiro R, Azevedo I, Coelho A, Soares M, Sousa B, et al. Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer—a review of the literature. The Oncologist. 2007;12:201–210
  11. Shahbazi M, Pravica V, Nasreen N, Fakhoury H, Fryer AA, Strange RC, et al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet. 2002;359:397–401
  12. McCarron SL, Bateman AC, Theaker JM, Howell WM. EGF +61 gene polymorphism and susceptibility to and prognostic markers in cutaneous malignant melanoma. Int J Cancer. 2003;107:673–675
  13. Randerson-Moor JA, Gaut R, Turner F, Whitaker L, Barrett JH, Silva Idos S, et al. The relationship between the epidemal growth factor (EGF) 5′UTR variant A61G and melanoma/nevus susceptibility. J Invest Dermatol. 2004;123:755–759
  14. Amend KL, Elder JT, Tomsho L, Bonner JD, Johnson TM, Schwartz J, et al. EGF gene polymorphism and the risk of incident primary melanoma. Cancer Res. 2004;64:2668–2672
  15. Lanuti M, Liu G, Goodwin JM, Zhai R, Fuchs BC, Asomaning K, et al. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res. 2008;14:3216–3222
  16. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B. Interaction of EGFR 497Arg>Lys with EGF +61A>G polymorphism: modulation of risk in esophageal cancer. Oncol Res. 2008;17:167–174
  17. Cui L, Pan XM, Pan CF, Shang-Guan J, Yu HB, Chen GX, et al. Association between epidermal growth factor polymorphism and esophageal squamous cell carcinoma susceptibility. Dig Dis Sci. 2009;[Epub ahead of print]
  18. Goto Y, Ando T, Goto H, Hamajima N. No association between EGF gene polymorphism and gastric cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:2454–2456
  19. Hamai Y, Matsumura S, Matsusaki K, Kitadai Y, Yoshida K, Yamaguchi Y, et al. A single nucleotide polymorphism in the 50 untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer. Pathobiology. 2005;72:133–138
  20. Jin G, Miao R, Deng Y, Hu Z, Zhou Y, Tan Y, et al. Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. Cancer Sci. 2007;98:864–868
  21. Bhowmick DA, Zhuang Z, Wait SD, Weil RJ. A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res. 2004;64:1220–1223
  22. Vauleon E, Auger N, Benouaich-Amiel A, Laigle-Donadey F, Kaloshi G, Lejeune J, et al. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet. 2007;172:33–37
  23. Costa BM, Ferreira P, Costa S, Canedo P, Oliveira P, Silva A, et al. Association between functional EGF 61 polymorphism and glioma risk. Clin Cancer Res. 2007;13:2621–2626
  24. Wang Y, Tian T, Hu ZB, Tang J, Wang S, Wang X, et al. EGF promoter SNPs, plasma EGF levels and risk of breast cancer in Chinese women. Breast Cancer Res Treat. 2008;111:321–327
  25. Araújo AP, Ribeiro R, Pinto D, Pereira D, Sousa B, Mauricio J, et al. Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease. DNA Cell Biol. 2009;28:265–269
  26. Lim YJ, Kim JW, Song JY, Hong MS, Jin SY, Yoon SH, et al. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett. 2005;374:157–160
  27. Kang HG, Choi JE, Lee WK, Kam S, Cha SI, Kim CH, et al. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer. Respirology. 2007;12:902–905
  28. Kang S, Kim JW, Park NH, Song YS, Park SY, Kang SB, et al. Epidermal growth factor 61A/G polymorphism and uterine cervical cancer. Int J Gynecol Cancer. 2007;17:492–496
  29. Wu GY, Hasenberg T, Magdeburg R, Bönninghoff R, Sturm JW, Keese M. Association between EGF, TGF-b1, VEGF gene polymorphism and colorectal cancer. World J Surg. 2009;33:124–129
  30. Vishnoi M, Pandey SN, Modi DR, Kumar A, Mittal B. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor B1-1-509C>T gene polymorphisms with gallbladder cancer. Hum Immunol. 2008;69:360–367
  31. Gao LB, Wei YS, Zhou B, Wang YY, Liang WB, Li C, et al. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma. Cancer Genet Cytogenet. 2008;185:69–73
  32. Araújo AP, Ribeiro R, Pereira D, Pinto D, Sousa B, Catarino R, et al. Ovarian cancer and genetic susceptibility: association of A61G polymorphism in the EGF. Gene Exp Biol Med. 2009;234:241–245
  33. Teixeira AL, Ribeiro R, Cardoso D, Pinto D, Lobo F, Fraga A, et al. Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients. Clin Cancer Res. 2008;14:3367–3371
  34. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19:251–253
  35. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820–826
  36. Zheng H, Wang Z, Shi X, Wang Z. XRCC1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer. 2009;65:268–273
  37. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558
  38. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  39. Egger M, Smith DG, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  40. Worm M, Makki A, Dippel E, Czarnetzki BM, Schadendorf D. Interferon-gamma down regulates epidermal growth factor receptors on human melanoma cells. Exp Dermatol. 1995;4:305
  41. Laurence DJ, Gusterson BA. The epidermal growth factor. A review of structural and functional relationships in the normal organism and in cancer cells. Tumor Biol. 1990;11:229–261
  42. Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem. 1990;265:7709–7712
  43. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract. 2003;93:29–34

PII: S1877-7821(10)00022-6

doi: 10.1016/j.canep.2010.02.004

Cancer Epidemiology
Volume 34, Issue 2 , Pages 150-156 , April 2010

Article Tools

* Image Usage & Resolution